Ganjana Lertmemongkolchai Selected Research

Melioidosis

12/2021	Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis.
2/2021	Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates.
7/2018	BPSL1626: Reverse and Structural Vaccinology Reveal a Novel Candidate for Vaccine Design against Burkholderia pseudomallei.
1/2018	Melioidosis in Thailand: Present and Future.
1/2018	A Rapid Immunochromatography Test Based on Hcp1 Is a Potential Point-of-Care Test for Serological Diagnosis of Melioidosis.
1/2018	Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes.
1/2017	Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei.
1/2017	Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.
11/2016	Flexible vs Rigid Epitope Conformations for Diagnostic- and Vaccine-Oriented Applications: Novel Insights from the Burkholderia pseudomallei BPSL2765 Pal3 Epitope.
10/2016	Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ganjana Lertmemongkolchai Research Topics

Disease

27	Melioidosis 12/2021 - 09/2007
26	Infections 01/2022 - 02/2006
5	Bacterial Infections (Bacterial Infection) 01/2020 - 08/2009
5	Sepsis (Septicemia) 07/2018 - 09/2007
3	Diarrhea 01/2020 - 01/2018
3	Inflammation (Inflammations) 01/2018 - 01/2009
2	Human Influenza (Influenza) 01/2020 - 01/2019
2	Tuberculosis (Tuberculoses) 01/2020 - 01/2018
2	Lymphadenopathy 01/2020 - 01/2020
2	Burkholderia Infections 01/2019 - 10/2017
2	Cystic Fibrosis (Mucoviscidosis) 12/2014 - 01/2011
2	Glanders 01/2011 - 09/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Growth Disorders 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Nontuberculous Mycobacterium Infections 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Acute Disease 01/2018
1	Convalescence 01/2018
1	Suppuration 01/2017
1	Cryptococcosis 01/2017
1	Fibrosis (Cirrhosis) 10/2015
1	Atrial Fibrillation 01/2014
1	Dengue (Dengue Fever) 09/2010
1	Virus Diseases (Viral Diseases) 09/2010
1	Neglected Diseases 01/2009

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 01/2020 - 02/2006
11	VaccinesIBA 07/2018 - 09/2006
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2009
8	EpitopesIBA 01/2019 - 01/2011
7	CytokinesIBA 01/2017 - 02/2006
5	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020 - 11/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 04/2015
4	AutoantibodiesIBA 01/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2009
3	MicronutrientsIBA 01/2020 - 01/2018
3	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 09/2010
3	ZincIBA 01/2020 - 01/2018
3	TabletsIBA 01/2020 - 01/2018
3	PowdersIBA 01/2020 - 01/2018
3	AntibodiesIBA 01/2019 - 04/2015
3	Peptides (Polypeptides)IBA 11/2016 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 10/2015
2	Messenger RNA (mRNA)IBA 05/2015 - 09/2006
2	Interleukin-27 (Interleukin 27)IBA 12/2012 - 09/2006
1	Complement System Proteins (Complement)IBA 01/2022
1	Biological ProductsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Imipenem FDA Link 02/2021
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 02/2021
1	Meropenem (Merrem)FDA LinkGeneric 02/2021
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2021
1	LactamsIBA 02/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Hemin (Panhematin)FDA Link 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	IronIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	ImmunosorbentsIBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	Hemolysin Proteins (Hemolysins)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	EnzymesIBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Lipoproteins (Lipoprotein)IBA 10/2017
1	Peptidoglycan (Murein)IBA 10/2017
1	Immune Sera (Antisera)IBA 11/2016
1	CollagenIBA 10/2015
1	Metalloproteases (Metalloproteinases)IBA 10/2015
1	PeroxiredoxinsIBA 05/2015
1	B7-H1 AntigenIBA 05/2015
1	Type V Secretion SystemsIBA 01/2015
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2014
1	FlagellinIBA 12/2014
1	PotassiumIBA 01/2014
1	Recombinant ProteinsIBA 09/2013
1	Superoxides (Superoxide)IBA 08/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2011
1	Viral AntigensIBA 09/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2010
1	InterferonsIBA 01/2009
1	Polysaccharides (Glycans)IBA 01/2009
1	Subunit VaccinesIBA 01/2009
1	Bacterial Proteins (Bacterial Protein)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2006
1	Interleukin-6 (Interleukin 6)IBA 09/2006
1	Interleukin-12 Subunit p35IBA 09/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2007
2	Immunotherapy 01/2019 - 01/2018
2	Glycemic Control 01/2014 - 11/2013